ARCHIVES

HOP Development Proceeding Guidelines For New, Revision Of Existing Control Grants Being Written

This article is from The Cancer Letter archive.

Vol. 07 No. 30 | July 24, 1981

Download PDF Visit The Full Archive

Related Articles

Amgen Pays $24.9 Million To Settle Kickback Charges

April 19, 2013

Health Reform Bill Contains Unpleasant Surprises For Drug Manufacturers

November 5, 1993

Acceptance Of Sentinel Node Biopsy Is Growing, Study Finds

October 31, 2003

NCI “Can’t Justify Size Of Intramural Program”

May 12, 1995

ACCC Annual Meeting To Study Organizing Community Care

January 26, 1979

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

September 29, 2006